Why Omnicell (OMCL) Might be Well Poised for a Surge

18.12.24 18:20 Uhr

Werte in diesem Artikel
Aktien

1,39 EUR 0,00 EUR 0,00%

41,20 EUR 0,40 EUR 0,98%

Indizes

19.630,2 PKT 291,9 PKT 1,51%

Omnicell (OMCL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this Omnicell Inc. Reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.For Omnicell, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:12 Month EPSCurrent-Quarter Estimate RevisionsThe earnings estimate of $0.57 per share for the current quarter represents a change of +72.73% from the number reported a year ago.The Zacks Consensus Estimate for Omnicell has increased 9.57% over the last 30 days, as one estimate has gone higher compared to no negative revisions.Current-Year Estimate RevisionsFor the full year, the company is expected to earn $1.68 per share, representing a year-over-year change of -12.04%.In terms of estimate revisions, the trend for the current year also appears quite encouraging for Omnicell. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 10.67%.Favorable Zacks RankThe promising estimate revisions have helped Omnicell earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineInvestors have been betting on Omnicell because of its solid estimate revisions, as evident from the stock's 6.6% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omnicell, Inc. (OMCL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf :be

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf :be

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Omnicell Inc.

Wer­bung

Analysen zu Omnicell Inc.

DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
06.03.2009Omnicell holdBB&T Capital Markets
19.12.2008Omnicell averageCaris & Company, Inc.
11.06.2008Omnicell above averageCaris & Company, Inc.
01.02.2008Omnicell averageCaris & Company, Inc.
05.12.2007Omnicell averageCaris & Company, Inc.
DatumRatingAnalyst
22.01.2009Omnicell DowngradeBB&T Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicell Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"